Researchers examine unanticipated benefits of GLP-1 medications
GLP-1 receptor agonists and dual agonists have transformed the treatment of obesity and other metabolic diseases, and a new editorial co-authored by Dr. Steven Heymsfield of LSU's Pennington Biomedical Research Center and ...
Aug 14, 2026
0
373









